|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.070 HKD | -6.16% |
|
-0.49% | -4.27% |
| Jul. 16 | CSPC Pharma Begins Two Drug Trials in China | MT |
| Jul. 15 | CSPC Pharma's Breast Cancer Drug Combination Granted China Breakthrough Designation | MT |
| Market Cap | 98.32B 12.54B 10.96B 10.14B 9.3B 17.61B 1,209B 17.91B 121B 47.5B 590B 47.1B 46.07B 2,038B | P/E 2026 * |
11.9x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 87.46B 11.16B 9.75B 9.02B 8.28B 15.66B 1,075B 15.94B 108B 42.25B 525B 41.9B 40.98B 1,812B | EV / Sales 2026 * |
2.45x | EV / Sales 2027 * | 2.41x |
| Free-Float |
67.42% | Yield 2026 * |
4.22% | Yield 2027 * | 4.28% |
| 1 day | -6.16% | ||
| 1 week | -0.49% | ||
| Current month | +15.78% | ||
| 1 month | +16.45% | ||
| 3 months | -9.93% | ||
| 6 months | -17.15% | ||
| Current year | -4.27% |
| 1 week | 7.9 |  | 8.72 |
| 1 month | 6.53 | | 8.72 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.9 |
| 10 years | 3.47 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 2025-12-18 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 2025-12-18 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 2011-08-25 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 2012-01-19 |
Bo Wang
BRD | Director/Board Member | 66 | 2012-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 | Other | Chief Operating Officer | -1,400,000 | 0.0122% | ||
| 6/23/26 | Other | Director | -700,000 | 0.0061% | ||
| 6/22/26 | Other | Chairman | 14,650,000 | 0.1271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.16% | -0.49% | -9.93% | +27.69% | 12.54B | |
| +1.08% | -3.93% | +48.03% | +160.13% | 1,043B | |
| +1.19% | -3.52% | +51.70% | +56.36% | 602B | |
| +4.21% | +1.79% | +33.48% | +87.04% | 449B | |
| +0.42% | -1.16% | +29.43% | +22.27% | 327B | |
| +1.03% | -0.84% | +29.58% | +45.08% | 279B | |
| +0.49% | -5.44% | +21.00% | +22.32% | 264B | |
| +3.70% | +2.19% | +24.27% | +63.38% | 201B | |
| +3.49% | +1.08% | +24.08% | +76.58% | 169B | |
| +1.29% | +3.67% | +2.15% | -30.78% | 143B | |
| Average | +0.80% | +0.35% | +25.38% | +53.01% | 348.96B | |
| Weighted average by Cap. | +1.65% | -1.77% | +36.91% | +82.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35.68B 4.55B 3.98B 3.68B 3.38B 6.39B 439B 6.5B 43.87B 17.24B 214B 17.09B 16.72B 739B | 35.2B 4.49B 3.92B 3.63B 3.33B 6.3B 433B 6.41B 43.28B 17B 211B 16.86B 16.49B 729B |
| Net income | 7.94B 1.01B 885M 818M 751M 1.42B 97.56B 1.45B 9.76B 3.83B 47.64B 3.8B 3.72B 164B | 6.92B 882M 771M 713M 655M 1.24B 85.02B 1.26B 8.51B 3.34B 41.52B 3.31B 3.24B 143B |
| Net Debt | -10.86B -1.39B -1.21B -1.12B -1.03B -1.95B -134B -1.98B -13.36B -5.25B -65.2B -5.2B -5.09B -225B | -13.44B -1.71B -1.5B -1.39B -1.27B -2.41B -165B -2.45B -16.53B -6.49B -80.67B -6.44B -6.3B -278B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | HK$8.070 | -6.16% | 87,259,200 |
| 26-07-16 | HK$8.600 | +2.02% | 128,510,184 |
| 26-07-15 | HK$8.430 | +3.95% | 177,601,778 |
| 26-07-14 | HK$8.110 | -0.61% | 103,704,147 |
| 26-07-13 | HK$8.160 | +0.62% | 110,035,025 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
